Talkspace Income from Continuous Operations 2020-2025 | TALK

Talkspace income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Talkspace Annual Income from Continuous Operations
(Millions of US $)
2024 $1
2023 $-19
2022 $-80
2021 $-63
2020 $-22
2019 $-29
Talkspace Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $-1
2025-03-31 $0
2024-12-31 $1
2024-09-30 $2
2024-06-30 $0
2024-03-31 $-1
2023-12-31 $-1
2023-09-30 $-4
2023-06-30 $-5
2023-03-31 $-9
2022-12-31 $-18
2022-09-30 $-18
2022-06-30 $-23
2022-03-31 $-20
2021-12-31 $-21
2021-09-30 $2
2021-06-30 $-30
2021-03-31 $-13
2020-12-31 $-19
2020-09-30 $-3
2020-06-30 $-1
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.429B $0.188B
Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.855B 58.34
Tempus AI (TEM) United States $12.818B 0.00
Doximity (DOCS) United States $12.199B 54.28
Hims & Hers Health (HIMS) United States $10.401B 85.22
IRhythm Technologies (IRTC) United States $5.159B 0.00
Hinge Health (HNGE) United States $4.608B 0.00
Privia Health (PRVA) United States $2.610B 193.36
Inspire Medical Systems (INSP) United States $2.596B 38.16
Heartflow (HTFL) $2.530B 0.00
Phreesia (PHR) United States $1.708B 0.00
Enovis (ENOV) United States $1.689B 8.93
10x Genomics (TXG) United States $1.663B 0.00
Omnicell (OMCL) United States $1.456B 28.04
Schrodinger (SDGR) United States $1.426B 0.00
Azenta (AZTA) United States $1.393B 60.78
Clover Health Investments (CLOV) United States $1.358B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.092B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Zepp Health (ZEPP) Netherlands $0.491B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Carlsmed (CARL) $0.360B 0.00
Butterfly Network (BFLY) United States $0.360B 0.00
TruBridge (TBRG) United States $0.289B 50.74
Outset Medical (OM) United States $0.236B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.193B 0.00
CapsoVision (CV) United States $0.178B 0.00
MDxHealth SA (MDXH) Belgium $0.135B 0.00
American Well (AMWL) United States $0.115B 0.00
CareCloud (CCLD) United States $0.110B 5.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.064B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.035B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00